• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

清道夫受体a介导糖化低密度脂蛋白跨内皮细胞转胞吞作用,以促进动脉粥样硬化。

Scavenger receptor a mediates glycated LDL transcytosis across endothelial cells to promote atherosclerosis.

作者信息

Cheng Wenzhuo, Shu Meng, Kuang Liwen, Bai Xiangli, Jia Xiong, Zhao Ying, Lu Yajing, Zhu Lin, Wang Li, Zhu Yan, Shu Yan, Song Yi, Jin Si

机构信息

Department of Endocrinology, Institute of Geriatric Medicine, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Department of Pediatrics, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China.

出版信息

Int J Biol Macromol. 2023 Apr 30;235:123836. doi: 10.1016/j.ijbiomac.2023.123836. Epub 2023 Feb 25.

DOI:10.1016/j.ijbiomac.2023.123836
PMID:36849072
Abstract

Glycated low-density lipoprotein (G-LDL) is an established proatherosclerotic factor, but the mechanism is not completely understood. In vitro, we evaluated the uptake and transcytosis rates of N-LDL and G-LDL in endothelial cells and the uptake and transcytosis rates of G-LDL were much higher than those of N-LDL. Then, using small interfering RNAs, the receptor mediating G-LDL uptake and transcytosis was screened among eight candidate receptors, and the mechanism of the receptor regulation was thoroughly examined. We discovered that scavenger receptor A (SR-A) knockdown dramatically decreased the uptake and transcytosis rates of G-LDL. Additionally, endothelial cells with overexpressed SR-A had enhanced G-LDL uptake and transcytosis. In vivo, G-LDL was injected in the tail vein of ApoE mice to investigate whether G-LDL affects atherosclerotic plaque formation. Compared with the injection of N-LDL, the injection of G-LDL accelerated atherosclerotic plaque formation in ApoE mice, which was ameliorated by endothelial cells specific SR-A knockdown. Together, our results provide the first demonstration that the transcytosis of G-LDL across endothelial cells is much faster than that of N-LDL and SR-A is the major type of receptor responsible for G-LDL binding and transcytosis across endothelial cells.

摘要

糖化低密度脂蛋白(G-LDL)是一种已确定的促动脉粥样硬化因子,但其机制尚未完全明确。在体外实验中,我们评估了内皮细胞中天然低密度脂蛋白(N-LDL)和糖化低密度脂蛋白(G-LDL)的摄取和转胞吞率,结果显示G-LDL的摄取和转胞吞率远高于N-LDL。随后,我们利用小干扰RNA在8种候选受体中筛选介导G-LDL摄取和转胞吞的受体,并深入研究该受体的调控机制。我们发现,敲低清道夫受体A(SR-A)可显著降低G-LDL的摄取和转胞吞率。此外,过表达SR-A的内皮细胞对G-LDL的摄取和转胞吞能力增强。在体内实验中,我们通过尾静脉注射G-LDL至载脂蛋白E(ApoE)基因敲除小鼠体内,以研究G-LDL是否影响动脉粥样硬化斑块的形成。与注射N-LDL相比,注射G-LDL加速了ApoE小鼠动脉粥样硬化斑块的形成,而内皮细胞特异性敲低SR-A可改善这一现象。综上所述,我们的研究首次证实,G-LDL在内皮细胞中的转胞吞速度远快于N-LDL,且SR-A是介导G-LDL在内皮细胞上结合与转胞吞的主要受体类型。

相似文献

1
Scavenger receptor a mediates glycated LDL transcytosis across endothelial cells to promote atherosclerosis.清道夫受体a介导糖化低密度脂蛋白跨内皮细胞转胞吞作用,以促进动脉粥样硬化。
Int J Biol Macromol. 2023 Apr 30;235:123836. doi: 10.1016/j.ijbiomac.2023.123836. Epub 2023 Feb 25.
2
C-reactive protein promotes atherosclerosis by increasing LDL transcytosis across endothelial cells.C反应蛋白通过增加低密度脂蛋白跨内皮细胞的转胞吞作用来促进动脉粥样硬化。
Br J Pharmacol. 2014 May;171(10):2671-84. doi: 10.1111/bph.12616.
3
VCAM-1-binding peptide targeted cationic liposomes containing NLRP3 siRNA to modulate LDL transcytosis as a novel therapy for experimental atherosclerosis.靶向 VCAM-1 结合肽的载 NLRP3siRNA 阳离子脂质体调节 LDL 转胞吞作用作为实验性动脉粥样硬化的新疗法。
Metabolism. 2022 Oct;135:155274. doi: 10.1016/j.metabol.2022.155274. Epub 2022 Jul 30.
4
Estrogen Inhibits LDL (Low-Density Lipoprotein) Transcytosis by Human Coronary Artery Endothelial Cells via GPER (G-Protein-Coupled Estrogen Receptor) and SR-BI (Scavenger Receptor Class B Type 1).雌激素通过 G 蛋白偶联雌激素受体(GPER)和清道夫受体 B 类 1(SR-BI)抑制人冠状动脉内皮细胞 LDL(低密度脂蛋白)的转胞吞作用。
Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2283-2294. doi: 10.1161/ATVBAHA.118.310792.
5
Deacetylation of Caveolin-1 by Sirt6 induces autophagy and retards high glucose-stimulated LDL transcytosis and atherosclerosis formation.Sirt6介导的Caveolin-1去乙酰化可诱导自噬,并抑制高糖刺激的低密度脂蛋白转胞吞作用及动脉粥样硬化形成。
Metabolism. 2022 Jun;131:155162. doi: 10.1016/j.metabol.2022.155162. Epub 2022 Feb 12.
6
Endothelial HMGB1 Is a Critical Regulator of LDL Transcytosis via an SREBP2-SR-BI Axis.内皮细胞高迁移率族蛋白 B1 通过 SREBP2-SR-BI 轴调控 LDL 跨细胞转运。
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):200-216. doi: 10.1161/ATVBAHA.120.314557. Epub 2020 Oct 15.
7
Serum amyloid A and interleukin -1β facilitate LDL transcytosis across endothelial cells and atherosclerosis via NF-κB/caveolin-1/cavin-1 pathway.血清淀粉样蛋白 A 和白细胞介素 -1β 通过 NF-κB/小窝蛋白 1/窖蛋白 1 通路促进 LDL 穿越内皮细胞和动脉粥样硬化。
Atherosclerosis. 2023 Jun;375:87-97. doi: 10.1016/j.atherosclerosis.2023.03.004. Epub 2023 Mar 12.
8
SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis.SR-B1 通过 DOCK4 驱动内皮细胞 LDL 胞吞作用,从而促进动脉粥样硬化。
Nature. 2019 May;569(7757):565-569. doi: 10.1038/s41586-019-1140-4. Epub 2019 Apr 24.
9
Genetic or therapeutic neutralization of ALK1 reduces LDL transcytosis and atherosclerosis in mice.ALK1 的遗传或治疗性中和可减少小鼠的 LDL 胞吞作用和动脉粥样硬化。
Nat Cardiovasc Res. 2023 May;2(5):438-448. doi: 10.1038/s44161-023-00266-2. Epub 2023 May 11.
10
TNF-α promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells: crosstalk between NF-κB and PPAR-γ.TNF-α 通过增加 LDL 在内皮细胞中的穿越转运促进早期动脉粥样硬化:NF-κB 和 PPAR-γ 之间的串扰。
J Mol Cell Cardiol. 2014 Jul;72:85-94. doi: 10.1016/j.yjmcc.2014.02.012. Epub 2014 Mar 2.

引用本文的文献

1
How Does HDL Participate in Atherogenesis? Antioxidant Activity Versus Role in Reverse Cholesterol Transport.高密度脂蛋白如何参与动脉粥样硬化形成?抗氧化活性与逆向胆固醇转运中的作用
Antioxidants (Basel). 2025 Apr 2;14(4):430. doi: 10.3390/antiox14040430.
2
Mechanisms of Abnormal Lipid Metabolism in the Pathogenesis of Disease.疾病发病机制中的异常脂质代谢机制。
Int J Mol Sci. 2024 Aug 2;25(15):8465. doi: 10.3390/ijms25158465.